Combined impact of high body mass index and in vitro fertilization on preeclampsia risk: A hospital-based cohort study

Obesity

Volumn 23, Issue 1, 2015, Pages 200-206

  Dayan, Natalie ^a,b   Pilote, Louise ^a,b   Opatrny, Lucie ^c   Basso, Olga ^a,b   Messerlian, Carmen ^b   El Messidi, Amira ^a   Daskalopoulou, Stella S ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ST MARY S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; MATERNAL WELFARE; OBESITY; PREECLAMPSIA; PREGNANCY; RISK ASSESSMENT; RISK FACTOR; TERTIARY CARE CENTER; COMPLICATION; HOSPITALIZATION; OVERWEIGHT; PRE-ECLAMPSIA; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; BODY MASS INDEX; CANADA; COHORT STUDIES; FEMALE; FERTILIZATION IN VITRO; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; OBESITY; OVERWEIGHT; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 84928301134     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20896     Document Type: Article

References (40)

1. Statistics Canada. Adult Obesity Prevalence in Canada and the United States, 2011. Available at: http://www.statcan.gc.ca/chms. Accessed on May 15, 2014.
2. Koning AM, Mutsaerts MA, Kuchenbecker WKH, Broekmans FJ, Land JA, Mol BWJ, Hoek A,. Complications and outcome of assisted reproduction technologies in overweight and obese women. Hum Reprod 2012; 27: 457-467.
3. Balasch J, Gratacos E,. Delayed childbearing: Effects on fertility and the outcome of pregnancy. Curr Opin Obstet Gynecol 2012; 24: 187-193.
4. James PT, Leach R, Kalamara E, Shayeghi M,. The worldwide obesity epidemic. Obes Res 2001; 9 Suppl 4: 228s-233s.
5. Jackson RA, Gibson KA, Wu YW, Croughan MS,. Perinatal outcomes in singletons following in vitro fertilization: A meta-analysis. Obstet Gynecol 2004; 103: 551-563.
6. Basso O, Weinberg CR, Baird DD, Wilcox AJ, Olsen J,. Subfecundity as a correlate of preeclampsia: A study within the Danish National Birth Cohort. Am J Epidemiol 2003; 157: 195-202.
7. Pandey S, Maheshwari A, Bhattacharya S,. Should access to fertility treatment be determined by female body mass index? Hum Reprod 2010; 25: 815-820.
8. Tulandi T, King L, Zelkowitz P,. Public funding of and access to in vitro fertilization. N Engl J Med 2013; 368: 1948-1949.
9. Centre for Public Health Excellence at Nice, National Collaborating Centre for Primary Care. National Institute for Health and Clinical Excellence: Guidance. Obesity: The Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. London: National Institute for Health and Clinical Excellence (UK); 2006.
10. Koning AM, Kuchenbecker WK, Groen H, Hoek A, Land JA, Khan KS, Mol BWJ,. Economic consequences of overweight and obesity in infertility: A framework for evaluating the costs and outcomes of fertility care. Hum Reprod Update 2010; 16: 246-254.
11. Fedorcsak P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, Omland AK, Abyholm T, Tanbo T,. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004; 19: 2523-2528.
12. Moragianni VA, Jones SM, Ryley DA,. The effect of body mass index on the outcomes of first assisted reproductive technology cycles. Fertil Steril 2012; 98: 102-108.
13. Udell JA, Lu H, Redelmeier DA,. Long-term cardiovascular risk in women prescribed fertility therapy. J Am Coll Cardiol 2013; 62: 1704-1712.
14. Joy S, Istwan N, Rhea D, Desch C, Stanziano G,. The impact of maternal obesity on the incidence of adverse pregnancy outcomes in high-risk term pregnancies. Am J Perinatol 2009; 26: 345-349.
15. El-Chaar D FS, Tu X, Fell DB, Gaudet L, Sylvain J, Tawagi G, Wen SW, Walker M,. The impact of increasing obesity class on obstetrical outcomes. J Obstet Gynaecol Can 2013; 35: 224-233.
16. Athukorala C, Rumbold AR, Willson KJ, Crowther CA,. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy Childbirth 2010; 10: 56. doi: 10.1186/1471-2393-10-56.
17. Dennedy MC, Avalos G, O'Reilly MW, O'Sullivan EP, Gaffney G, Dunne F,. ATLANTIC-DIP: Raised maternal body mass index (BMI) adversely affects maternal and fetal outcomes in glucose-tolerant women according to International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. J Clin Endocrinol Metab 2012; 97: E608-612.
18. Magee LA, Helewa M, Moutquin JM, von Dadelszen P,. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008; 30 (3 Suppl): S1-48.
19. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R,. Pre-eclampsia. Lancet 2010; 376: 631-644.
20. Bellamy L, Casas JP, Hingorani AD, Williams DJ,. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ 2007; 335: 974. doi: http://dx.doi.org/10.1136/bmj.39335.385301.
21. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA,. Cardiovascular health after maternal placental syndromes (CHAMPS): Population-based retrospective cohort study. Lancet 2005; 366 (9499): 1797-1803.
22. Buckett WM, Chian RC, Holzer H, Dean N, Usher R, Tan SL,. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol 2007; 110: 885-891.
23. Allen VM, Wilson RD, Cheung A,. Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can 2006; 28: 220-250.
24. Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, VanDorsten JP, LAndon M, Midovnik M, Paul R, Meis P, Thurnau G, Dombrowski M, Roberts J, McNellis D,. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000; 182: 938-942.
25. Society of Obstetrics and Gynaecologists of Canada (SOGC)-Canadian Fertility and Andrology Society (CFAS). Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006. Int J Gynaecol Obstet 2008; 102: 203-216.
26. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW,. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. Can Med Assoc J 1997; 157: 715-725.
27. American College of Obstetritians and Gynecologists (ACOG). ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, Jan 2002. Obstet Gynecol 2002; 99: 159-167.
28. Weinberg CR,. Toward a clearer definition of confounding. Am J Epidemiol 1993; 137: 1-8.
29. Knol MJ, VanderWeele TJ,. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol 2012; 41: 514-520.
30. Salha O, Sharma V, Dada T, Nugent D, Rutherford AJ, Tomlinson AJ, Philips S, Allgar V, Walker JJ,. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod 1999; 14: 2268-2273.
31. Nieto-Garcia FJ, Bush TL, Keyl PM,. Body mass definitions of obesity: Sensitivity and specificity using self-reported weight and height. Epidemiology 1990; 1: 146-152.
32. Shields M, Connor Gorber S, Janssen I, Tremblay MS,. Bias in self-reported estimates of obesity in Canadian health surveys: An update on correction equations for adults. Health Rep 2011; 22: 35-45.
33. Hernandez LM, Blazer DG, Institute of Medicine (U.S.). Committee on Assessing Interactions Among Social Behavioral and Genetic Factors in Health. Genes, Behavior, and the Social Environment: Moving Beyond the Nature/Nurture Debate. Washington, DC: National Academies Press; 2006.
34. Greenland S,. Tests for interaction in epidemiologic studies: A review and a study of power. Stat Med 1983; 2: 243-251.
35. Selvin S,. Statistical Analysis of Epidemiologic Data. 2nd ed. New York: Oxford University Press; 1996.
36. Knol MJ, VanderWeele TJ, Groenwold RH, Klungel OH, Rovers MM, Grobbee DE,. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011; 26: 433-438.
37. Qin JZ, Pang LH, Li MJ, Fan XJ, Huang RD, Chen HY,. Obstetric complications in women with polycystic ovary syndrome: A systematic review and meta-analysis. Reprod Biol Endocrinol 2013; 11: 56. http://www.rbej.com/content/11/1/56.
38. Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A,. Obesity and reproductive disorders in women. Hum Reprod Update 2003; 9: 359-372.
39. Catalano PM,. Obesity, insulin resistance, and pregnancy outcome. Reproduction 2010; 140: 365-371.
40. Jones SML, Moragianni VA, Ryley DA,. Obesity significantly decreases live birth rate (LBR) following in vitro fertilization (IVF), even after controlling for all potential confounders. Fertil Steril 2011; 96: S82.